Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-17, Stock:PFE, The news for the past five days is as follows:
2019-06-10: NEWS1: INMB: TNF-α Inhibition Associated with Decreased Risk of Developing Alzheimer’s Disease….NEWS2: Health Care Sector Update for 06/10/2019: INSY, TLRY, ONCE, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 06/10/2019: INSY, TLRY, ONCE, JNJ, PFE, ABT, MRK, AMGN.NEWS4: TherapeuticsMD Enters Agreement to Market Drugs Outside US.NEWS5: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS6: Jim Cramer Weighs In On Tesla, PayPal And More.
2019-06-11: NEWS1: Health Care Sector Update for 06/11/2019: CBAY, MOTS, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS2: Health Care Sector Update for 06/11/2019: CBAY, MOTS, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS3: See what the IHS Markit Score report has to say about Pfizer Inc..
2019-06-12: NEWS1: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS2: Novartis Reports Data on Cosentyx for Psoriatic Arthritis.NEWS3: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS4: Top Ranked Income Stocks to Buy for June 12th.NEWS5: Top Ranked Income Stocks to Buy for June 12th.NEWS6: Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer.NEWS7: Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer.NEWS8: Top Ranked Income Stocks to Buy for June 12th.NEWS9: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS10: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS11: Health Care Sector Update for 06/12/2019: SYBX, CTRV, AXGT, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 06/12/2019: SYBX, CTRV, AXGT, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer.NEWS14: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS15: Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor.
2019-06-13: NEWS1: Stocks Bounce Back Amid U.S.-Iran Tanker Tensions.NEWS2: Stocks Bounce Back Amid U.S.-Iran Tanker Tensions.NEWS3: Market Close Report: NASDAQ Composite index closes at 7,837.13 up 44.41 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 7,837.13 up 44.41 points.NEWS5: J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns definitive ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB.NEWS6: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS7: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS8: Health Care Sector Update for 06/13/2019: SVRA, TNXP, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 06/13/2019: SVRA, TNXP, PRVB, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2019.NEWS11: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2019.NEWS12: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS13: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS14: Novartis Reports Data on Cosentyx for Psoriatic Arthritis.NEWS15: Novartis Reports Data on Cosentyx for Psoriatic Arthritis.NEWS16: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS17: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS18: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS19: Pfizer (PFE) Gains As Market Dips: What You Should Know.
2019-06-14: NEWS1: Dow Movers: INTC, UTX.NEWS2: Dow Movers: INTC, UTX.NEWS3: Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti.NEWS4: Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti.NEWS5: Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout.NEWS6: Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout.NEWS7: Merck Plans Its First Investor Day in 5 Years. Here’s What to Watch..NEWS8: Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout.NEWS9: Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti.

Answer: Rise